DUSP22r ALK − ALCL is usually associated with a favorable prognosis, with 5-year OS rates ranging from 80 to 90% [15–18], although some studies have demonstrated poorer prognoses [15, 19, 20], with clinical factors also playing a role [17]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.